Skip to main content
. 2020 May 11;15:1039–1047. doi: 10.2147/COPD.S219731

Table 3.

Quantitative Computed Tomography Values for Subjects with Scans Performed at 2, 6 (Treatment Completion) and 18 Months (One Year After Treatment Completion)

n=20 2 Months 6 Months 18 Months Change 2 to 6 Months Change 6 to 18 Months Change 2 to 18 Months
Median (IQR) Median (IQR) Median (IQR) P-valuec P-valuec P-valuec
TLC (L) 3.91 (3.14–4.44) 4.01 (3.39–4.57) 4.06 (3.46–4.69) 0.01 0.99 0.16
RV (L) 1.89 (1.58–2.36) 1.79 (1.56–2.19) 1.96a (1.65–2.19) 0.41 0.86 0.77
LAA (%b) 9.07% (4.57–11.04) 8.76% (6.78–11.63) 9.84% (7.75–14.45) 0.20 0.11 0.02
GTS (%b) 5.26% (2.79–9.16) 6.85% (4.23–10.98) 7.13%a (4.79–15.87) 0.19 0.04 0.02
QLF (%) 2.15% (1.31–3.41) 1.14% (0.72–1.67) 0.76% (0.57–1.55) <0.01 0.11 <0.01
QLF (mL) 84.67 (63.50–139.12) 38.30 (31.51–69.51) 30.48 (21.85–72.13) <0.01 0.07 <0.01

Notes: an=19. bPercentage of total lung volume. cP-value for paired Wilcoxon test.

Abbreviations: TLC, total lung capacity; RV, residual volume; LAA, low-attenuation areas on inspiratory scan (ie,<-950HU, emphysema score); GTS, gas-trapping score on expiratory scan (ie, <-856HU); QLF, quantity of lung fibrosis; L, litres; mL, milliliters.